Cervical Squamous Intraepithelial Lesion
Conditions
Interventions
Safety Evaluation Group:Bijieshu female antibacterial gel
Therapeutic effect evaluation group:Bijieshu female antibacterial gel
Sponsors
Zhejiang Cancer Hospital
Eligibility
Sex/Gender
Female
Age
20 Years to 74 Years
Inclusion criteria
Inclusion criteria: (1) a biopsy-confirmed tissue diagnosis of CIN1/2/3 (2) HPV infection and (3) agreement and ability to comply with the study protocol requirements.
Exclusion criteria
Exclusion criteria: (1) allergy to CVG (2) patients with unsatisfactory colposcopy (3) history of invasive cervical carcinoma or other invasive malignancies (4) presence of skin and mucosal infections or overt pyometra (5) acute inflammation of the female reproductive tract (6) pregnancy or breastfeeding (7) Other serious conditions that may significantly affect compliance with clinical studies such as unstable heart disease requiring treatment kidney disease chronic hepatitis poorly controlled diabetes and mental illness.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The condition of SIL turning negative; | — |
Secondary
| Measure | Time frame |
|---|---|
| safety;HPV results; | — |
Countries
China
Contacts
Public ContactHanmei Lou
Zhejiang Cancer Hospital
Outcome results
None listed